Αποτελέσματα Αναζήτησης
24 Αυγ 2021 · This article provides an overview of primary malignant and nonmalignant brain and other CNS tumor incidence, mortality, and survival rates and trends in the United States, as well as differences in occurrence by major histologic subtype, anatomic site, geography, race/ethnicity, and sex.
Brain and other nervous system cancer represents 1.3% of all new cancer cases in the U.S. In 2024, it is estimated that there will be 25,400 new cases of brain and other nervous system cancer and an estimated 18,760 people will die of this disease.
The Graded Prognostic Assessment (GPA) estimates survival for patients with brain metastases. Survival and the factors that predict survival vary by diagnosis and the molecular profile of the patient's tumor.
Malignant brain tumor incidence rates declined by 0.8% annually from 2008 to 2017 for all ages combined but increased 0.5% to 0.7% per year among children and adolescents. Malignant brain tumor incidence is highest in males and non-Hispanic White individuals, whereas the rates for nonmalignant tumors are highest in females and non-Hispanic ...
Similarly, stable or decreasing incidence rates of malignant brain tumours (glioma and glioblastoma) were reported across all age groups in 2000–2014 in a summary of the most recent and comprehensive data on rates of malignant and non-malignant brain tumours for 99.9% of the population of the USA (Fig. 5.17.4) .
About 25,400 malignant tumors of the brain or spinal cord (14,420 in males and 10,980 in females) will be diagnosed. These numbers would be much higher if benign (non-cancer) tumors were also included. About 18,760 people (10,690 males and 8,070 females) will die from brain and spinal cord tumors.
The latest brain tumour survival statistics for the UK for Health Professionals. See data for sex, age, trends over time and more.
